サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1731959

ビリルビン測定器の世界市場

Bilirubin Meters

出版日
ページ情報
英文 454 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.73円
ビリルビン測定器の世界市場
出版日: 2025年05月23日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 454 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ビリルビン測定器の世界市場は2030年までに19億米ドルに達する見込み

2024年に13億米ドルと推定されたビリルビン測定器の世界市場は、2030年には19億米ドルに達し、分析期間2024-2030年のCAGRは6.8%で成長すると予測されます。本レポートで分析したセグメントの1つであるベンチトップビリルビン測定器は、CAGR 7.9％を記録し、分析期間終了までに13億米ドルに達すると予測されています。経皮ビリルビン測定器セグメントの成長率は、分析期間でCAGR 4.3％と推定されます。

米国市場は3億4,130万米ドルと推定、中国はCAGR 10.8％で成長予測

米国のビリルビン測定器市場は、2024年に3億4,130万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを10.8%として、2030年までに3億8,960万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.3％と6.6％と予測されています。欧州では、ドイツがCAGR 4.5%で成長すると予測されています。

世界のビリルビン測定器市場- 主要動向と促進要因のまとめ

ビリルビン測定器が新生児や肝臓の健康管理で臨床的重要性を増している理由とは？

ビリルビン測定器は、臨床診断、特に新生児黄疸と肝臓関連疾患の早期発見とモニタリングにおいて、ますます必要不可欠になってきています。これらのデバイスは、血液中または経皮スクリーニングによるビリルビン濃度を測定するための迅速で非侵襲的、または低侵襲的な手段を提供し、肝機能、溶血、代謝クリアランスに関するタイムリーな洞察を提供します。新生児高ビリルビン血症は、新生児における最も一般的な臨床症状の1つであるため、ビリルビン測定器を用いた早期スクリーニングは、カーニクテルスやビリルビン誘発性神経機能障害（BIND）などの合併症を予防するために非常に重要です。

新生児医療に加え、ビリルビン測定器は成人の肝機能障害、胆道閉塞、溶血性疾患のモニタリングにも活用されています。母子保健プログラムにおける早期介入の世界の優先順位と相まって、ポイントオブケア診断が重視されるようになり、病院、分娩センター、小児科外来での採用が進んでいます。ヘルスケアプロバイダーが、所要時間を短縮し、患者の処理能力を向上させるリアルタイムのビリルビン評価ツールを求めているため、これらのメーターは最前線の診断資産として関連性を増しています。

テクノロジーの強化とワークフローの統合は、ビリルビン測定器の性能をどのように向上させているか？

ビリルビン測定器における技術の進歩は、測定精度、ユーザーの利便性、診断の一貫性を向上させています。現在、経皮ビリルビン測定器は、高度な分光光度法と多波長光学センサーを使用して、非侵襲的にビリルビン濃度を検出し、新生児における採血の必要性を最小限に抑えています。これらの機器は、さまざまな肌色、妊娠年齢、臨床状態にわたって再現性のある測定ができるように設計されており、新生児ICUや産後病棟での普及を支えています。

タッチスクリーンインターフェース、自動較正機能、ワイヤレス接続を備えたハンドヘルドのポータブルモデルは、電子カルテ（EHR）や病院情報システムへの統合を容易にしています。データロギング機能を備えたバッテリー駆動のデザインは機動性を高め、地方のアウトリーチプログラムや外来環境、在宅での新生児モニタリングでの使用を可能にしています。メーカー各社はまた、小型化、センサーの高精度化、ビリルビン測定とヘモグロビンや酸素飽和度パラメータを組み合わせたデュアル機能モデルにも注力しており、小児科や肝疾患の診断ワークフローにおける有用性の幅を広げています。

ビリルビン測定器の需要はどこで高まり、どのような医療現場で採用が進んでいるか？

北米や欧州のような新興国市場で需要が最も高まっており、そこでは普遍的な新生児スクリーニング・プロトコールと強固な臨床インフラが黄疸の早期発見をサポートしています。アジア太平洋地域は、出生率の高さ、新生児医療へのアクセスの拡大、周産期合併症をターゲットとした公衆衛生上の取り組みにより、高成長地域として浮上しています。インド、中国、インドネシア、ベトナムなどの国々では、予防可能な乳幼児の罹患率や死亡率を減らすために、公的医療施設と民間医療施設の両方でビリルビン測定器の調達が増加しています。

一次的な採用は、新生児集中治療室（NICU）、産科病院、小児科クリニックに集中しています。また、地域保健プログラムや助産ネットワークでは、産後の家庭訪問時に早期スクリーニングを行うための携帯型ビリルビノメーターを備えるところが増えています。成人医療では、肝疾患クリニックや肝移植センターが、肝機能パネル診断の一環として、検査室ベースのビリルビン分析器に依存しています。ユニバーサル・ヘルス・カバレッジと地方における健康の公平性をめぐる世界の取り組みが強化される中、正確なビリルビン・モニタリングへの分散型アクセスは、診断能力構築の重要な要素となりつつあります。

ビリルビン測定器市場の世界的成長の原動力は？

ビリルビン測定器市場の世界的成長の原動力は、新生児医療水準の向上、母子保健の優先順位付け、黄疸発見の遅れがもたらす結果に対する意識の高まりです。技術革新、非侵襲的スクリーニングツールに対する規制支援、モバイルヘルスプラットフォームとの統合により、これらのデバイスは高リソース・低リソース両方のヘルスケアシステムでよりアクセスしやすく、拡張可能になっています。また、より迅速な診断と介入を目指し、ベッドサイドでのリアルタイム検査へと臨床がシフトしていることも、需要を後押ししています。

官民パートナーシップ、国際保健団体を通じた寄付、乳幼児保健プログラムによる政府調達の増加により、新興経済国での市場浸透が加速しています。メーカー各社は、最前線の医療従事者向けに設計された、使いやすくメンテナンスの軽いモデルで製品ラインを拡大しています。患者の安全性、早期介入、診断の分散化が引き続きヘルスケアの優先事項を形成する中、重要な疑問が浮上しています。ビリルビン測定器市場は、普遍的な新生児スクリーニングや、世界の医療エコシステム全体にわたる広範な肝機能監視をサポートするために、非侵襲的で高精度のソリューションを十分な速度で拡大できるだろうか？

セグメント

製品（ベンチトップ、経皮）、適応症（黄疸、肝炎）、年齢層（新生児、成人）、エンドユーザー（病院＆介護施設、クリニック、その他エンドユーザー）

調査対象企業の例（全34件）

  • Advanced Instruments, LLC
  • Apel Co., Ltd.
  • AVI Healthcare Pvt. Ltd.
  • Danaher Corporation
  • DAS Srl
  • Dragerwerk AG & Co. KGaA
  • F. Hoffmann-La Roche Ltd.
  • Ginevri Srl
  • GPC Medical Ltd.
  • Hadleigh Health Technologies
  • ICEN Technology Company Limited
  • Koninklijke Philips N.V.
  • Labtron Equipment Ltd.
  • Mennen Medical Ltd.
  • Micro Lab Instruments
  • Mindray Bio-Medical Electronics Co., Ltd.
  • Natus Medical Incorporated
  • Ningbo David Medical Device Co., Ltd.
  • Siemens Healthineers AG
  • Xuzhou Kejian Hi-tech Co., Ltd.

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・業界団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストを含む1万4,949人のエコノミストを追跡しています。当社の16,491を超えるレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP33551

Global Bilirubin Meters Market to Reach US$1.9 Billion by 2030

The global market for Bilirubin Meters estimated at US$1.3 Billion in the year 2024, is expected to reach US$1.9 Billion by 2030, growing at a CAGR of 6.8% over the analysis period 2024-2030. Benchtop Bilirubin Meters, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Transcutaneous Bilirubin Meters segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$341.3 Million While China is Forecast to Grow at 10.8% CAGR

The Bilirubin Meters market in the U.S. is estimated at US$341.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$389.6 Million by the year 2030 trailing a CAGR of 10.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 6.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Bilirubin Meters Market - Key Trends & Drivers Summarized

Why Are Bilirubin Meters Gaining Clinical Importance in Neonatal and Hepatic Health Management?

Bilirubin meters are becoming increasingly essential in clinical diagnostics, particularly for early detection and monitoring of neonatal jaundice and liver-related disorders. These devices offer a rapid, non-invasive or minimally invasive means of measuring bilirubin concentration in blood or through transcutaneous screening-providing timely insight into liver function, hemolysis, and metabolic clearance. As neonatal hyperbilirubinemia remains one of the most common clinical conditions in newborns, early screening using bilirubin meters is critical to preventing complications such as kernicterus and bilirubin-induced neurologic dysfunction (BIND).

In addition to neonatal care, bilirubin meters are being utilized in monitoring hepatic dysfunction, biliary obstruction, and hemolytic diseases in adults. The growing emphasis on point-of-care diagnostics, coupled with the global prioritization of early intervention in maternal and infant health programs, is driving adoption across hospitals, birthing centers, and outpatient pediatric care. As healthcare providers seek real-time bilirubin assessment tools that reduce turnaround times and improve patient throughput, these meters are gaining relevance as frontline diagnostic assets.

How Are Technology Enhancements and Workflow Integration Advancing Bilirubin Meter Performance?

Technological advancements in bilirubin meters are improving measurement accuracy, user convenience, and diagnostic consistency. Transcutaneous bilirubinometers now use advanced spectrophotometry and multi-wavelength optical sensors to detect bilirubin levels non-invasively, minimizing the need for blood draws in neonates. These devices are designed for repeatable measurements across different skin tones, gestational ages, and clinical conditions-supporting widespread adoption in neonatal ICUs and postnatal wards.

Handheld, portable models with touchscreen interfaces, auto-calibration features, and wireless connectivity are facilitating integration into electronic health records (EHRs) and hospital information systems. Battery-operated designs with data logging capabilities enhance mobility and enable use in rural outreach programs, ambulatory settings, and home-based newborn monitoring. Manufacturers are also focusing on miniaturization, sensor precision, and dual-function models that combine bilirubin measurement with hemoglobin or oxygen saturation parameters-broadening their utility within pediatric and hepatic diagnostic workflows.

Where Is Demand for Bilirubin Meters Rising and Which Care Settings Are Driving Adoption?

Demand is strongest in developed markets such as North America and Europe, where universal newborn screening protocols and robust clinical infrastructure support early jaundice detection. Asia-Pacific is emerging as a high-growth region due to high birth rates, expanding neonatal care access, and public health initiatives targeting perinatal complications. Countries such as India, China, Indonesia, and Vietnam are witnessing increased procurement of bilirubin meters in both public and private healthcare facilities to reduce preventable infant morbidity and mortality.

Primary adoption is concentrated in neonatal intensive care units (NICUs), maternity hospitals, and pediatric clinics. Community health programs and midwifery networks are also increasingly equipped with portable bilirubinometers for early screening during postnatal home visits. In adult medicine, hepatology clinics and liver transplant centers rely on lab-based bilirubin analyzers as part of liver function panel diagnostics. With global efforts intensifying around universal health coverage and rural health equity, decentralized access to accurate bilirubin monitoring is becoming a critical component of diagnostic capacity-building.

What Is Fueling the Global Growth of the Bilirubin Meters Market?

The global growth of the bilirubin meters market is being driven by rising neonatal care standards, the prioritization of maternal and child health, and growing awareness of the consequences of delayed jaundice detection. Technological innovation, regulatory support for non-invasive screening tools, and integration with mobile health platforms are making these devices more accessible and scalable across both high- and low-resource healthcare systems. Demand is also reinforced by the clinical shift toward real-time, bedside testing for faster diagnosis and intervention.

Public-private partnerships, donations through global health organizations, and increased government procurement under infant health programs are accelerating market penetration in emerging economies. Manufacturers are expanding product lines with user-friendly, maintenance-light models designed for frontline health workers. As patient safety, early intervention, and diagnostic decentralization continue to shape healthcare priorities, a critical question emerges: Can the bilirubin meter market scale non-invasive, high-accuracy solutions fast enough to support universal newborn screening and broader hepatic health surveillance across global care ecosystems?

SCOPE OF STUDY:

The report analyzes the Bilirubin Meters market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Benchtop, Transcutaneous); Indication (Jaundice, Hepatitis); Age Group (Neonatal, Adults); End-User (Hospitals & Nursing Homes, Clinics, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Advanced Instruments, LLC
  • Apel Co., Ltd.
  • AVI Healthcare Pvt. Ltd.
  • Danaher Corporation
  • DAS Srl
  • Dragerwerk AG & Co. KGaA
  • F. Hoffmann-La Roche Ltd.
  • Ginevri Srl
  • GPC Medical Ltd.
  • Hadleigh Health Technologies
  • ICEN Technology Company Limited
  • Koninklijke Philips N.V.
  • Labtron Equipment Ltd.
  • Mennen Medical Ltd.
  • Micro Lab Instruments
  • Mindray Bio-Medical Electronics Co., Ltd.
  • Natus Medical Incorporated
  • Ningbo David Medical Device Co., Ltd.
  • Siemens Healthineers AG
  • Xuzhou Kejian Hi-tech Co., Ltd.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Bilirubin Meters - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Neonatal Jaundice Drives Global Demand for Point-of-Care Bilirubin Meters
    • Non-Invasive Transcutaneous Meters Gain Preference in Pediatric and Maternity Care Settings
    • Real-Time Bilirubin Monitoring Enhances Early Intervention and Reduces Hospital Readmission
    • Integration With EHRs and Smart Monitoring Platforms Increases Clinical Workflow Efficiency
    • Portable and Handheld Devices Expand Bilirubin Testing in Low-Resource and Rural Healthcare Environments
    • Calibration Accuracy and Phototherapy Threshold Alerts Strengthen Utility in NICU Applications
    • Growth in Home-Based Newborn Care and Midwife Services Increases Use of Compact Bilirubin Meters
    • Regulatory Approvals and Safety Certifications Influence Vendor Selection in Pediatric Units
    • Multi-Parameter Devices Combining Jaundice and Vital Monitoring Improve Adoption in Newborn Bundles
    • Technology Advancements in Optical Sensors Improve Diagnostic Speed and Reliability
    • Public Health Initiatives for Infant Screening Expand Access to Bilirubin Testing in Developing Regions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Bilirubin Meters Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Bilirubin Meters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Bilirubin Meters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Bilirubin Meters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Benchtop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Benchtop by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Benchtop by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Transcutaneous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Transcutaneous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Transcutaneous by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Jaundice by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Jaundice by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Jaundice by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hepatitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hepatitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Hepatitis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Neonatal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Neonatal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Neonatal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Adults by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Adults by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Adults by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals & Nursing Homes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals & Nursing Homes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Hospitals & Nursing Homes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Bilirubin Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • JAPAN
    • Bilirubin Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • CHINA
    • Bilirubin Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • EUROPE
    • Bilirubin Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Bilirubin Meters by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Bilirubin Meters by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Bilirubin Meters by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • FRANCE
    • Bilirubin Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 95: France Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: France 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 98: France Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: France 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: France 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 104: France Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: France Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: France 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • GERMANY
    • Bilirubin Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Germany 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 110: Germany Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Germany 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 113: Germany Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Germany Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Germany 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 116: Germany Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Germany Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Germany 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 119: Italy Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Italy Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Italy 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 122: Italy Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Italy Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Italy 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 125: Italy Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Italy Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Italy 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 128: Italy Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Italy Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Italy 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Bilirubin Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 131: UK Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: UK Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: UK 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 134: UK Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: UK Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: UK 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 137: UK Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: UK Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: UK 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 140: UK Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: UK Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: UK 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 143: Spain Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Spain Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Spain 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 146: Spain Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Spain Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Spain 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 149: Spain Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Spain Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Spain 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 152: Spain Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Spain Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Spain 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 155: Russia Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Russia Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Russia 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 158: Russia Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Russia Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Russia 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 161: Russia Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Russia Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Russia 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 164: Russia Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Russia Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Russia 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 167: Rest of Europe Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Europe Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Europe 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 170: Rest of Europe Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Europe Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Rest of Europe 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Rest of Europe Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Rest of Europe 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Europe Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Rest of Europe 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Bilirubin Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 179: Asia-Pacific Recent Past, Current & Future Analysis for Bilirubin Meters by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 180: Asia-Pacific Historic Review for Bilirubin Meters by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Asia-Pacific 15-Year Perspective for Bilirubin Meters by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 182: Asia-Pacific Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Asia-Pacific Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Asia-Pacific 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Asia-Pacific Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Asia-Pacific 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Asia-Pacific Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Asia-Pacific 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Asia-Pacific Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Asia-Pacific 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Bilirubin Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 194: Australia Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Australia Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Australia 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 197: Australia Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Australia Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Australia 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 200: Australia Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Australia Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Australia 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 203: Australia Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Australia Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Australia 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • INDIA
    • Bilirubin Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 206: India Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: India Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: India 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 209: India Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: India Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: India 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 212: India Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: India Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: India 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 215: India Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: India Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: India 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 218: South Korea Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: South Korea Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: South Korea 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 221: South Korea Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: South Korea Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: South Korea 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 224: South Korea Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: South Korea Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: South Korea 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 227: South Korea Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: South Korea Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: South Korea 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 230: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Asia-Pacific Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Asia-Pacific 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 233: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Asia-Pacific Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Asia-Pacific 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Asia-Pacific Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Asia-Pacific 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Asia-Pacific Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Asia-Pacific 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Bilirubin Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 242: Latin America Recent Past, Current & Future Analysis for Bilirubin Meters by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 243: Latin America Historic Review for Bilirubin Meters by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Latin America 15-Year Perspective for Bilirubin Meters by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 245: Latin America Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Latin America Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Latin America 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 248: Latin America Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Latin America Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Latin America 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 251: Latin America Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Latin America Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Latin America 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 254: Latin America Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Latin America Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Latin America 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 257: Argentina Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Argentina Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Argentina 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 260: Argentina Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Argentina Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Argentina 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 263: Argentina Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Argentina Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Argentina 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 266: Argentina Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Argentina Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Argentina 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 269: Brazil Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Brazil Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Brazil 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 272: Brazil Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Brazil Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Brazil 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 275: Brazil Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Brazil Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Brazil 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 278: Brazil Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Brazil Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Brazil 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 281: Mexico Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Mexico Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: Mexico 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 284: Mexico Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Mexico Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: Mexico 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 287: Mexico Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Mexico Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: Mexico 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 290: Mexico Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Mexico Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Mexico 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 293: Rest of Latin America Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Latin America Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Latin America 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Latin America Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Latin America Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Latin America 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Latin America Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Latin America Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Latin America 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Latin America Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Latin America 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Bilirubin Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 305: Middle East Recent Past, Current & Future Analysis for Bilirubin Meters by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 306: Middle East Historic Review for Bilirubin Meters by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Middle East 15-Year Perspective for Bilirubin Meters by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 308: Middle East Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Middle East Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 310: Middle East 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 311: Middle East Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Middle East Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 313: Middle East 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 314: Middle East Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Middle East Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 316: Middle East 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 317: Middle East Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Middle East Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 319: Middle East 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 320: Iran Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Iran Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 322: Iran 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 323: Iran Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Iran Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 325: Iran 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 326: Iran Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Iran Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 328: Iran 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 329: Iran Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Iran Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 331: Iran 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 332: Israel Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Israel Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 334: Israel 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 335: Israel Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Israel Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 337: Israel 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 338: Israel Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Israel Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 340: Israel 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 341: Israel Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Israel Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 343: Israel 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 344: Saudi Arabia Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Saudi Arabia Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 346: Saudi Arabia 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 347: Saudi Arabia Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Saudi Arabia Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 349: Saudi Arabia 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 350: Saudi Arabia Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Saudi Arabia Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 352: Saudi Arabia 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Saudi Arabia Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 355: Saudi Arabia 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 356: UAE Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 357: UAE Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 358: UAE 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 359: UAE Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 360: UAE Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 361: UAE 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 362: UAE Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 363: UAE Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 364: UAE 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 365: UAE Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 366: UAE Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 367: UAE 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 368: Rest of Middle East Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 369: Rest of Middle East Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 370: Rest of Middle East 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 371: Rest of Middle East Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 372: Rest of Middle East Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 373: Rest of Middle East 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 374: Rest of Middle East Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 375: Rest of Middle East Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 376: Rest of Middle East 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 378: Rest of Middle East Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 379: Rest of Middle East 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030
  • AFRICA
    • Bilirubin Meters Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 380: Africa Recent Past, Current & Future Analysis for Bilirubin Meters by Product - Benchtop and Transcutaneous - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 381: Africa Historic Review for Bilirubin Meters by Product - Benchtop and Transcutaneous Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 382: Africa 15-Year Perspective for Bilirubin Meters by Product - Percentage Breakdown of Value Sales for Benchtop and Transcutaneous for the Years 2015, 2025 & 2030
    • TABLE 383: Africa Recent Past, Current & Future Analysis for Bilirubin Meters by Indication - Jaundice and Hepatitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 384: Africa Historic Review for Bilirubin Meters by Indication - Jaundice and Hepatitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 385: Africa 15-Year Perspective for Bilirubin Meters by Indication - Percentage Breakdown of Value Sales for Jaundice and Hepatitis for the Years 2015, 2025 & 2030
    • TABLE 386: Africa Recent Past, Current & Future Analysis for Bilirubin Meters by Age Group - Neonatal and Adults - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 387: Africa Historic Review for Bilirubin Meters by Age Group - Neonatal and Adults Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 388: Africa 15-Year Perspective for Bilirubin Meters by Age Group - Percentage Breakdown of Value Sales for Neonatal and Adults for the Years 2015, 2025 & 2030
    • TABLE 389: Africa Recent Past, Current & Future Analysis for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 390: Africa Historic Review for Bilirubin Meters by End-user - Hospitals & Nursing Homes, Clinics and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 391: Africa 15-Year Perspective for Bilirubin Meters by End-user - Percentage Breakdown of Value Sales for Hospitals & Nursing Homes, Clinics and Other End-Users for the Years 2015, 2025 & 2030

IV. COMPETITION